The role of colchicine in the management of COVID-19: a Meta-analysis
Abstract Background The Coronavirus disease 2019 (COVID-19) pandemic has robustly affected the global healthcare and economic systems and it was caused by coronavirus-2 (SARS-CoV-2). The clinical presentation of the disease ranges from a flu-like illness to severe pneumonia and death. Till September...
Main Authors: | Kholoud Elshiwy, Ghada Essam El-Din Amin, Mohamed Nazmy Farres, Rasha Samir, Mohamed Farouk Allam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-024-03001-0 |
Similar Items
-
Repurposing Colchicine in Treating Patients with COVID-19: A Systematic Review and Meta-Analysis
by: Chi-Hone Lien, et al.
Published: (2021-08-01) -
Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis
by: Carlos J. Toro-Huamanchumo, et al.
Published: (2022-05-01) -
Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials
by: Avinash Kumar Singh, et al.
Published: (2022-07-01) -
Cytokine storm and colchicine potential role fighting SARS-CoV-2 pneumonia
by: Antonio Vitiello, et al.
Published: (2020-04-01) -
Impact of colchicine on mortality and morbidity in COVID-19: a systematic review
by: Devang Sanghavi, et al.
Published: (2022-12-01)